Wolfgang Berger
advisory board
Anesthesiology
Stada
Russian Federation
Biography
STADA Business Model Focus on products with off-patent active pharmaceutical ingredients in the health care and pharmaceutical market Segments Generics (59% share in adjusted Group sales) Branded Products (41% share in adjusted Group sales) Strategic success factors Orientation on long-term growth markets Comprehensive portfolio of generics including selected biosimilars Attractive-margin branded product portfolio with increased internationalization of successful brands Strong product development including well-filled pipeline Global sales structure with further internationalization potential A focused acquisition policy A functional organizational structure with close-to-market sales companies Continuous cost optimization and efficient cost management Excellent and committed employees
Research Interest
pharma
